3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Wilms Tumor
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Hepatoblastoma
1
Carcinoma, Renal Cell
1
Interventions
Cyclophosphamide
14
Etoposide
12
Temozolomide
10
Carboplatin
9
Granulocyte Colony-Stimulating Factor
8
Filgrastim
8
Vincristine
7
etoposide phosphate
6
X-Rays
6
Thiotepa
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Cisplatin
6
Topotecan
5
Specimen Handling
5
Radiotherapy
5
Nuclear Medicine Department, Hospital
5
Methotrexate
5
fludarabine
4
Stem Cell Transplantation
4
Peripheral Blood Stem Cell Transplantation
4
Mesna
4
Melphalan
4
Biopsy
4
palbociclib
3
Sirolimus
3
Irinotecan
3
Ifosfamide
3
Busulfan
3
Automobiles
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rhabdoid Tumor
×
pegylated granulocyte colony-stimulating factor
×
CNS
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled